SE0102887D0 - New formulation - Google Patents
New formulationInfo
- Publication number
- SE0102887D0 SE0102887D0 SE0102887A SE0102887A SE0102887D0 SE 0102887 D0 SE0102887 D0 SE 0102887D0 SE 0102887 A SE0102887 A SE 0102887A SE 0102887 A SE0102887 A SE 0102887A SE 0102887 D0 SE0102887 D0 SE 0102887D0
- Authority
- SE
- Sweden
- Prior art keywords
- dosage form
- relates
- active substance
- extended release
- release oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
JP2003522503A JP2005504052A (ja) | 2001-08-29 | 2002-08-28 | 新規の徐放性経口製剤 |
US10/488,125 US20040197404A1 (en) | 2001-08-29 | 2002-08-28 | Extended release oral dosage form |
CNA028168712A CN1549705A (zh) | 2001-08-29 | 2002-08-28 | 新的缓释口服剂型 |
CA002457341A CA2457341A1 (fr) | 2001-08-29 | 2002-08-28 | Nouvelle forme posologique orale a liberation prolongee |
KR10-2004-7002920A KR20040032977A (ko) | 2001-08-29 | 2002-08-28 | 신규 지연 방출 경구 투여 제형 |
HU0401599A HUP0401599A3 (en) | 2001-08-29 | 2002-08-28 | Extended release oral dosage form |
BR0212167-0A BR0212167A (pt) | 2001-08-29 | 2002-08-28 | Forma de dosagem oral de liberação prolongada, uso da mesma, método para a prevenção e/ou tratamento de distúrbios e perturbações médicas, e, processo para a fabricação de uma forma de dosagem de liberação prolongada |
MXPA04001805A MXPA04001805A (es) | 2001-08-29 | 2002-08-28 | Nueva forma de dosificacion oral de liberacion prolongada. |
IL16037102A IL160371A0 (en) | 2001-08-29 | 2002-08-28 | A new extended release oral dosage form |
PCT/SE2002/001541 WO2003017983A1 (fr) | 2001-08-29 | 2002-08-28 | Nouvelle forme posologique orale a liberation prolongee |
EP02763155A EP1423099A1 (fr) | 2001-08-29 | 2002-08-28 | Nouvelle forme posologique orale a liberation prolongee |
ZA200401547A ZA200401547B (en) | 2001-08-29 | 2004-02-25 | A new extended release oral dosage form. |
NO20040857A NO20040857L (no) | 2001-08-29 | 2004-02-26 | Ny oral forlenget frigivelses doseringsform. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0102887D0 true SE0102887D0 (sv) | 2001-08-29 |
Family
ID=20285178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0102887A SE0102887D0 (sv) | 2001-08-29 | 2001-08-29 | New formulation |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040197404A1 (fr) |
EP (1) | EP1423099A1 (fr) |
JP (1) | JP2005504052A (fr) |
KR (1) | KR20040032977A (fr) |
CN (1) | CN1549705A (fr) |
BR (1) | BR0212167A (fr) |
CA (1) | CA2457341A1 (fr) |
HU (1) | HUP0401599A3 (fr) |
IL (1) | IL160371A0 (fr) |
MX (1) | MXPA04001805A (fr) |
NO (1) | NO20040857L (fr) |
SE (1) | SE0102887D0 (fr) |
WO (1) | WO2003017983A1 (fr) |
ZA (1) | ZA200401547B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1904067B2 (fr) * | 2004-12-03 | 2017-10-11 | Merck Sharp & Dohme Corp. | Formulation pharmaceutique de derives de carboxamide , inhibiteurs de l'hiv integrase, comprenant une composition a liberation contrôlee |
EP1946780B1 (fr) | 2005-11-11 | 2012-01-11 | Asahi Kasei Chemicals Corporation | Preparation solide a liberation controlee |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
GB0618879D0 (en) * | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
US20100069390A1 (en) | 2008-09-05 | 2010-03-18 | Supernus Pharmaceuticals, Inc. | Method of treatment of attention deficit/hyperactivity disorder (ADHD) |
AU2012336036A1 (en) * | 2011-11-07 | 2014-06-19 | Diakron Pharmaceuticals Inc. | An extended release formulation of a direct thrombin inhibitor |
US9358204B2 (en) * | 2012-02-08 | 2016-06-07 | Supernus Pharmaceuticals, Inc. | Formulations of viloxazine |
EP2822542A1 (fr) * | 2012-03-07 | 2015-01-14 | Santarus, Inc. | Formes posologiques solides à libération contrôlée de mésalamine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
US4837032A (en) * | 1986-02-04 | 1989-06-06 | Farval Ag | Theophylline sustained release tablet |
GB8624213D0 (en) * | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
AR035642A1 (es) * | 2000-05-26 | 2004-06-23 | Pharmacia Corp | Uso de una composicion de celecoxib para el alivio rapido del dolor |
-
2001
- 2001-08-29 SE SE0102887A patent/SE0102887D0/xx unknown
-
2002
- 2002-08-28 CA CA002457341A patent/CA2457341A1/fr not_active Abandoned
- 2002-08-28 HU HU0401599A patent/HUP0401599A3/hu unknown
- 2002-08-28 JP JP2003522503A patent/JP2005504052A/ja active Pending
- 2002-08-28 US US10/488,125 patent/US20040197404A1/en not_active Abandoned
- 2002-08-28 IL IL16037102A patent/IL160371A0/xx unknown
- 2002-08-28 KR KR10-2004-7002920A patent/KR20040032977A/ko not_active Application Discontinuation
- 2002-08-28 WO PCT/SE2002/001541 patent/WO2003017983A1/fr not_active Application Discontinuation
- 2002-08-28 BR BR0212167-0A patent/BR0212167A/pt not_active IP Right Cessation
- 2002-08-28 MX MXPA04001805A patent/MXPA04001805A/es unknown
- 2002-08-28 EP EP02763155A patent/EP1423099A1/fr not_active Withdrawn
- 2002-08-28 CN CNA028168712A patent/CN1549705A/zh active Pending
-
2004
- 2004-02-25 ZA ZA200401547A patent/ZA200401547B/en unknown
- 2004-02-26 NO NO20040857A patent/NO20040857L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04001805A (es) | 2004-07-08 |
ZA200401547B (en) | 2004-11-17 |
HUP0401599A2 (hu) | 2004-11-29 |
WO2003017983A1 (fr) | 2003-03-06 |
US20040197404A1 (en) | 2004-10-07 |
CN1549705A (zh) | 2004-11-24 |
HUP0401599A3 (en) | 2007-03-28 |
EP1423099A1 (fr) | 2004-06-02 |
KR20040032977A (ko) | 2004-04-17 |
BR0212167A (pt) | 2004-07-20 |
NO20040857L (no) | 2004-04-19 |
JP2005504052A (ja) | 2005-02-10 |
CA2457341A1 (fr) | 2003-03-06 |
IL160371A0 (en) | 2004-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
NO20055880L (no) | Memantin orale doseringsformer | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
SG146638A1 (en) | Pharmaceutical delivery system | |
HUP0203682A2 (hu) | Eljárás foszfodiészteráz-4 inhibitor beadására | |
SE0102887D0 (sv) | New formulation | |
EP1262197A3 (fr) | Combinaison thérapeutique pour traiter les troubles du sommeil, y compris l'apnée du sommeil | |
PL1656131T3 (pl) | Zastosowanie betainy w leczeniu chromania przestankowego | |
NZ535611A (en) | Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist | |
SE9902597D0 (sv) | New use | |
HUP0301408A2 (hu) | Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására | |
SE0102886D0 (sv) | New formulation | |
SE0102888D0 (sv) | New formulation | |
EA200901145A1 (ru) | Применение рибофлавина в лечении гипертензии | |
HK1075390A1 (en) | Citalopram for the treatment of elevated blood pressure | |
WO2004043486A8 (fr) | Formulation pharmaceutique aqueuse contenant l'inhibiteur de la thrombine melagatran et utilisation de cette formulation pour la preparation d'un medicament a administration nasale destine au traitement de la maladie thrombo-embolique | |
ATE464051T1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
SE0002354D0 (sv) | New formulation | |
ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
DE60113895D1 (de) | Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose | |
TH62247A (fr) |